Logo

Howard McLeod, Geoffrey Harris

Dec 04, 2014

Cancer Genetics has added Howard McLeod and Geoffrey Harris to its board of directors.

McLeod is the medical director of the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He joined Moffitt last year from the University of North Carolina's Institute for Pharmacogenomics and Individualized Therapy, of which he was the founding director.

Harris is a portfolio manager and managing partner at c7 Advisors, a healthcare advisory firm. Before c7 Advisors, Harris was managing director and co-head of the Cantor Fitzgerald Healthcare Investment Group from 2011 to 2014.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.